Fund moves

West Pharmaceutical Services (WST): Longview Partners (Guernsey) LTD added to its stake +184K shares

Longview Partners (Guernsey) LTD added to its stake in West Pharmaceutical Services, per its Q1 2026 13F.

1.32M
Shares reported · +184K vs prior quarter
4.7%
Disclosed portfolio weight
$330M
Reported value
Holdings as of
Mar 31, 2026
Filed
May 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  2. Apr 23, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  3. Apr 27, 2026Insider · 2 peopleInsiders: 2 sales (~$1.1M)
  4. Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.7%
  5. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  6. May 7, 2026Company filing · Form 8-K · Cyber incident, Reg FDReported a cybersecurity incident, and shared information with investors“On May 7, 2026, West Pharmaceutical Services, Inc. (the “Company”) determined that the Company has experienced a material cybersecurity attack, in which certain data was exfiltrated by an unauthorized party and certain systems were encrypted.”
  7. May 7, 2026Company filing · Form 8-K · Cyber incidentReported a cybersecurity incident“As previously disclosed in the Original Report, the Company determined on May 7, 2026 that the Company had experienced a material cybersecurity attack, in which certain data was exfiltrated by an unauthorized party and certain systems were encrypted.”

What came next

  1. May 31, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 9, 2026, West Pharmaceutical Services, Inc. (the “Company”) filed a Current Report on Form 8-K announcing that Mr. Eric M. Green, President, Chief Executive Officer and Chair of the Board of Directors (the “Board”) of the Company, informed the Board on March 6, 2026 of his intent to retire from those positions once his successor has been hired in order to ensure a smooth transition.”
  2. Jul 14, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  3. Jul 23, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  4. Aug 6, 20265% stakeFMR LLC reported a passive stake (13G) of 5.0%
  5. Sep 8, 2026Insider · 1 personInsiders: 3 sales (~$2.8M)
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for West Pharmaceutical Services

For West Pharmaceutical Services, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its WST page.

How this filing works

Explore the data

Common questions

What does this filing report about West Pharmaceutical Services (WST) stock?

Longview Partners (Guernsey) LTD added to its stake in West Pharmaceutical Services, per its Q1 2026 13F. Now 1.32M shares, $330M reported value, 4.7% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Mar 31, 2026. Filed: May 15, 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about West Pharmaceutical Services recently?

For West Pharmaceutical Services, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the WST page.

Does this mean WST stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at West Pharmaceutical Services

Everything OQRO holds on this company is on its WST page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data